Your browser doesn't support javascript.
loading
Pneumocystis jirovecii pneumonia as a complication of etoposide therapy.
Mendoza, Maria Alejandra; Iyer, Sunil; Camargo, Jose F; Benedetto, Pasquale W.
Afiliación
  • Mendoza MA; Internal Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA maria.mendoza2@jhsmiami.org.
  • Iyer S; Internal Medicine, University of Miami, Miami Beach, Florida, USA.
  • Camargo JF; Department of Medicine, Division of Infectious Diseases, University of Miami, Miami, Florida, USA.
  • Benedetto PW; Deparment of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, Florida, USA.
BMJ Case Rep ; 14(6)2021 Jun 10.
Article en En | MEDLINE | ID: mdl-34112634
ABSTRACT
Two patients receiving oral etoposide therapy developed Pneumocystis jirovecii pneumonia during chemotherapy with significant lymphopenia without corticosteroid use. In this commentary we discuss cellular mechanisms by which etoposide induced CD4+ T lymphocyte dysfunction and reduced survival may lead to predisposition to P. jirovecii infection.
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía por Pneumocystis / Pneumocystis carinii / Linfopenia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía por Pneumocystis / Pneumocystis carinii / Linfopenia Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article